HomeCompareSYK vs DOV

SYK vs DOV: Dividend Comparison 2026

SYK yields 1.04% · DOV yields 1.02%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SYK wins by $21.8K in total portfolio value
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
DOV
DOV
● Live price
1.02%
Share price
$202.81
Annual div
$2.08
5Y div CAGR
4.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.5K
Annual income
$172.40
Full DOV calculator →

Portfolio growth — SYK vs DOV

📍 SYK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKDOV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + DOV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
DOV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
DOV
Annual income on $10K today (after 15% tax)
$86.97/yr
After 10yr DRIP, annual income (after tax)
$146.54/yr
At 15% tax rate, SYK beats the other by $6,893.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + DOV for your $10,000?

SYK: 50%DOV: 50%
100% DOV50/50100% SYK
Portfolio after 10yr
$32.4K
Annual income
$4,227.69/yr
Blended yield
13.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
DOV
Analyst Ratings
18
Buy
10
Hold
Consensus: Buy
Price Target
$223.70
+10.3% upside vs current
Range: $195.00 — $256.00
Altman Z
5.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
DOV buys
9
PoliticianChamberTickerTypeAmountDate
Julie Johnson🏢 House$DOV▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$DOV▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$DOV▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$DOV▲ Buy$1,001 - $15,0002025-10-30
Julie Johnson🏢 House$DOV▼ Sell$1,001 - $15,0002025-08-14
James Comer🏢 House$DOV▼ Sell$1,001 - $15,0002025-07-03
Julia Letlow🏢 House$DOV▼ Sell$1,001 - $15,0002025-04-11
Rob Bresnahan🏢 House$DOV▲ Buy$1,001 - $15,0002025-04-08
James Comer🏢 House$DOV▲ Buy$1,001 - $15,0002025-01-02
Julia Letlow🏢 House$DOV▲ Buy$1,001 - $15,0002024-10-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKDOV
Forward yield1.04%1.02%
Annual dividend / share$3.40$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%4.5%
Portfolio after 10y$43.3K$21.5K
Annual income after 10y$8,282.98$172.40
Total dividends collected$21.0K$1.4K
Payment frequencyquarterlyquarterly
SectorHealthcareIndustrials
Analyst consensusBuyBuy
Analyst price target$428.67$223.70

Year-by-year: SYK vs DOV ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrDOV PortfolioDOV Income/yrGap
1← crossover$10,852$152.43$10,807$106.92+$45.00SYK
2$11,838$226.03$11,676$112.84+$162.00SYK
3$13,004$336.89$12,613$119.07+$391.00SYK
4$14,420$505.63$13,621$125.62+$799.00SYK
5$16,195$766.09$14,707$132.49+$1.5KSYK
6$18,504$1,175.64$15,876$139.71+$2.6KSYK
7$21,635$1,835.40$17,135$147.30+$4.5KSYK
8$26,082$2,932.10$18,490$155.26+$7.6KSYK
9$32,737$4,829.68$19,948$163.62+$12.8KSYK
10$43,312$8,282.98$21,516$172.40+$21.8KSYK

SYK vs DOV: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

DOVIndustrials

Dover Corporation provides equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services worldwide. The Engineered Products segment provides various equipment, component, software, solution, and services that are used in aftermarket vehicle service, solid waste handling, industrial automation, aerospace and defense, industrial winch and hoist, and fluid dispensing end-market. This segment also offers manual and power clamp, rotary and linear mechanical indexer, conveyor, pick and place unit, glove port, and manipulator, as well as end-of-arm robotic gripper, slide, and end effector. Its Clean Energy & Fueling segment offers component, equipment, and software and service solution enabling safe transport of traditional and clean fuel, and other hazardous substance along with supply chain, as well as operation of convenience retail, retail fueling, and vehicle wash establishment. The Imaging and Identification segment provides precision marking and coding; packaging intelligence; product traceability equipment; brand protection; and digital textile printing equipment, as well as related consumable, software, and service to packaged and consumer good, pharmaceutical, industrial manufacturing, fashion and apparel, and other end-market. Its Pumps and Process Solutions segment manufactures specialty pump, connector, and flow meter, fluid connecting solution, plastics and polymer processing equipment, and engineered components for rotating and reciprocating machines. The Climate & Sustainability Technologies segment manufactures refrigeration system, refrigeration display case, commercial glass refrigerator and freezer door, and brazed plate heat exchanger for industrial heating and cooling, and residential climate control applications. It sells its products directly and through a network of distributors. The company was incorporated in 1947 and is headquartered in Downers Grove, Illinois.

Full DOV Calculator →
📬

Get this SYK vs DOV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.